Thus, this study highlights the unique therapeutic potential of AuNP-NmAb in the EGFR+ target-specific treatment of cancers and promotes further studies involving clinical applications of AuNP-carrier-based mAb therapeutics for enhanced efficacy of mAbs against cancers. The gene discussed is EGFR; the disease is cancer.